Showing results (221-230 of 291) with videos related to

Sort By:
Pageof 30
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activityW H Miller, L M Beauchamp, E Meade, et al.
The Journal of Urology|March 1, 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reactionR S Israeli, W H Miller, S L Su, et al.
Blood|February 15, 1995
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)J D Licht, C Chomienne, A Goy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.
Blood|June 1, 1995
9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemiaW H Miller, A Jakubowski, W P Tong, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesvirusesD M Lowe, W K Alderton, M R Ellis, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group studyW H Miller, L M Reyno, G R Loewen, et al.
Arthritis and Rheumatism|February 24, 2001
Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritisA M Badger, S Blake, R Kapadia, et al.
Pageof 30